
Plerixafor 24 mg/1.2 mL (Mozifor) is a prescription medicine used to help move blood-forming stem cells from the bone marrow into the bloodstream. It is commonly used alongside filgrastim in patients with certain blood cancers, such as multiple myeloma and non-Hodgkin lymphoma, before stem cell collection for transplantation.
| Generic Name | Plerixafor |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 1 Vial |
| Prescribed For | Move stem cells from the bone marrow |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Plerixafor works by blocking the CXCR4 receptor, which helps keep blood-forming stem cells attached to the bone marrow. By interrupting this interaction, it allows more stem cells to move into the bloodstream, where they can be collected for transplantation.